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ABSTRACT
Background : Obesity is one of the most widespread epidemics of our time. In fact,
currently 65.7% of US adults age 20 and older are overweight, while 30.6% are obese.
It has been well-established that obesity has numerous adverse effects on long-term
health, however the specific effect on patients treated for sepsis and septic shock is
unclear. Body Mass Index (BMI) is a measure of total body fat content and surrogate
marker for obesity. In our study, we aimed to identify if BMI was an independent risk
factor for poor survival or increased length of stay (LOS) in patients with sepsis.
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Methods: We retrospectively selected patients with diagnostic codes of sepsis and septic
shock who were admitted to the ICU over three years. These patients were further
separated into groups of alive and deceased. Based on their perceived association
with mortality in sepsis, numerous variables were investigated, such as BMI, LOS, age,
cirrhosis, chronic kidney disease (CKD), lactate level, age, multiple organ dysfunction
syndrome (MODS), and APACHE II scores. Specifically, BMI was classified into sub-groups.
The alive and deceased groups were initially compared for any significant differences
with univariate analysis. Thereafter, the significant variables were analyzed using
multivariate analysis to assess whether any were able to independently predict mortality
in sepsis.
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Results : Our study selected 293 patients with sepsis, including 185 alive and 108
deceased. Interestingly, our univariate analysis revealed that underweight and obese
patients exhibited slightly less mortality in sepsis compared to normal and overweight
patients. However, these results did not reach statistical significance, with a p-value of
0.30; this was confirmed in multivariate analysis, which resulted in a p-value of 0.08.
Additionally, underweight, overweight, and obese patients had a slightly decreased
median LOS in the ICU and hospital compared to patients with normal BMI. Nevertheless,
these results were not significant either, with ICU LOS p-value of 0.22 and hospital LOS
p-value of 0.45.Univariate analysis identified certain variables that reached statistical
significance, including cirrhosis (p<0.01), CKD (p= 0.05), MODS>2 (p=0.03), median
lactate level (p=0.05), age (p<0.01), and APACHE II scores (p<0.01). Multivariate analysis
of these variables established that only the presence of cirrhosis (p=0.03), age (p<0.01),
and APACHE II scores (p<0.01) were independent predictors of mortality in sepsis.
Conclusion: The data suggests that normal BMI in patients with sepsis may result
in increased mortality and LOS both in the ICU and hospital, though this was not
statistically significant. Other variables that were significant independent predictors for
mortality in sepsis were cirrhosis, mean age, and mean APACHE II score. As the obesity
epidemic continues to rise, further inquiry into the association of BMI and mortality in
sepsis is needed.
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INTRODUCTION
Approximately 30% of the population in the United
States is obese.1 This is particularly alarming since
obesity is known to be directly related to conditions
such as cardiovascular disease, diabetes, and
hypertension.2,3,4 However, the effects of obesity are
not only limited to metabolic conditions, since there
is also an increased incidence in cancer and in allcause mortality.5 Body mass index (BMI) is a surrogate
marker for obesity, currently the best standard by
which to measure patient adiposity, and may be subclassified into underweight, normal, overweight, and
obese.6

admitted to the Cooper University Hospital (New
Jersey) ICU under the diagnostic codes of septic
shock over a period of 3 years. The total number
of patients sampled were 293, which were
subsequently separated into groups of 185 alive
patients and 108 deceased patients based on their
status by the end of their hospitalization. Variables
thought to be associated with mortality in septic
shock were collected and analyzed, including BMI,
cirrhosis, chronic kidney disease (CKD), albumin,
lactate level, age, multiple organ dysfunction
syndrome (MODS), and APACHE II scores.

As the prevalence of obesity is on the rise, the
number of obese patients admitted to the hospital
has increased in turn as well. This has further led to
increased costs incurred and greater national health
expenditure in the US.2,3,7 Many obese patients
suffer from multiple comorbidities, which has led to
an increase in the prevalence of the obese patient
population in the ICU. Sepsis is considered to be a
major contributing condition to the morbidity and
mortality in the ICU.8 Sepsis and obesity are both
considered to result in an increased length of stay
(LOS) and overall cost of medical treatment. Past
studies on patients with sepsis have advocated that
there is no significance in morbidity and mortality
after adjustment of the data has been done with
regard to BMI.8,9 Our study aimed to elucidate
the relationship between obesity, morbidity and
mortality outcomes, and LOS in patients with septic
shock.

Our inclusion criteria defined patients with septic
shock as those in need of vasopressors in spite of
adequate fluid resuscitation while having at least
two signs of systemic inflammation. Our exclusion
criteria were patients less than 18 years of age,
pregnant women, and patients with no recorded
height or weight. BMI was classified into sub-groups,
including underweight (BMI<18), normal (BMI 1824.9), overweight (BMI 25-29.9), and obese (BMI>30).
Initially, the two groups (alive and deceased patients)
were compared for any significant differences using
univariate analysis, including chi-squared and
t-tests as appropriate. Subsequently, each variable
found to be significant (p<0.05) was analyzed using
multivariate analysis, including logistic regression, to
evaluate whether any were independent predictors
of mortality in patients with septic shock. Finally, a
Kruskal-Wallis comparison of the weight categories
was done to determine if there was any significant
difference in the ICU LOS, which was then repeated
for hospital LOS.

METHODS

RESULTS

This is an Institutional Review Board (IRB) approved
study by Cooper University Hospital. The aim of this
study is to identify whether BMI is an independent
predictor of mortality or greater length of stay (LOS)
in patients with septic shock. We specifically focused
on BMI due to its prevalence in the population,10 as
well as its clinical correlation with poorer outcomes,
while also attempting to assess for indicators of
overall health and other comorbidities.

A total of 293 patients were selected for the study
between January 2008 and January 2011; these were
further divided into 185 alive and 108 deceased.
Numerous pertinent variables were identified
among the two groups and analyzed initially using
univariate analysis, after which the statistically
significant variables were further analyzed using
multivariate analysis. In the total sample of patients,
the mean age was 61.27 years old, with 51.9% men
and 48.1% women. Interestingly, our univariate
analysis revealed that underweight and obese

We retrospectively selected a sample of patients
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patients exhibited slightly less mortality in septic
shock compared to normal and overweight patients.
However, these results did not reach statistical
significance (p=0.30, Pearson’s chi-squared test;
Table 1), which was then confirmed in multivariate
analysis (OR 0.97, 95% CI 0.94-1.00, p=0.08; Table 2).
Univariate analysis identified certain variables that
reached statistical significance, including:
• cirrhosis (p<0.01, Fisher’s exact test) in 0.7% of
alive and 9.4% of deceased patients
• CKD (p=0.05, Pearson’s chi-squared test) in 15.7%
of alive and 25.0% of deceased patients
• MODS>2 (p=0.03, Pearson’s chi-squared test) in
76.2% of alive and 87.0% of deceased patients
• median lactate level within 24 hours (p=0.05,
Mann-Whitney U test) with interquartile range of
1.6-4.8 (median of 2.70) in alive patients and 1.95.4 (median of 3.50) in deceased patients
• age (p<0.01, independent samples) with mean
of 58.49 (SD 16.42) in alive and 66.03 (SD 14.71)
in deceased patients
• APACHE II scores (p<0.01, independent samples
T-test) with mean of 17.24 (SD 9.31) in alive and
23.95 (SD 10.39) in deceased patients (Table 3)
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Thereafter, multivariate analysis using logistic
regression of the aforementioned variables yielded
statistical significance in:
• cirrhosis (OR 11.43, 95% CI 1.25-104.92, p=0.03)
• age (OR 1.03, 95% CI 1.01-1.05, p<0.01)
• APACHE II scores (OR 1.07, 95% CI 1.04-1.11,
p<0.01)
Despite the lack of significance using univariate
analysis, since it was the focus of our study, BMI was
further evaluated with multivariate analysis, which
confirmed again that it was not significant (OR 0.97,
95% CI 0.94-1.00, p=0.08).
Finally, underweight, overweight, and obese patients
had a slightly decreased median LOS in the ICU and
hospital compared to patients with normal BMI.
Nevertheless, these results were not significant either
(ICU LOS p=0.22, hospital LOS p=0.45) (Table 4).
DISCUSSION
Medical paradoxes arise when surprising findings
contradict the expected logical or conventional
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wisdom. The obesity paradox with regard to sepsis
states that obesity should increase mortality in sepsis
due to the fact that it is a chronically heightened
inflammatory state with increased oxidative stress.
Numerous studies have revealed that while obese
patients have high morbidity, they interestingly have
lower mortality outcomes as compared to patients
with normal BMI.11,12 A meta-analyses by Pepper
et al, showed that patients in the ICU due to septic
parameters that had overweight or obese BMIs had
a reduced adjusted mortality compared to those
with a normal BMI..13 While this benefit may not be
completely understood, it can still be explained by
a number of reasons. Firstly, hypertension in obese
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patients from increased renin-angiotensin activity
may confer hemodynamic protection during sepsis
and decrease the necessity for fluid or vasopressor
support.13 Furthermore, hormones secreted from
adipose tissue may have an immunomodulatory
effect that limits the inflammatory response and
improves host survival.14 Finally, it may be that the
previous studies, such as the ones reviewed in the
aforementioned meta-analysis, may have weak
methodologies.
In 1987, adipose tissue was first recognized as a
major endocrine organ by Siiteri et al.15 Thereafter,
Ahima et al stated that adipose tissue functions as
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a complex endocrine organ.16 The major hormones
secreted by adipose tissue include adiponectin
and leptin. Moreover, the non-adipose portion
of adipose tissue is responsible for the secretion
of several proteins participating in the reninangiotensin aldosterone system. These include
angiotensinogen, angiotensin I, angiotensin II,
angiotensin II receptor type 1, angiotensin II receptor
type 2, and angiotensin-converting enzyme.17,18
In normal individuals, this leads to hypertension;
however, in states of hemodynamic instability
this has a protective effect, resulting in decreased
need for pressor support and less fluid required
for volume resuscitation. Recent multicenter trials
ARISE and PROMISE have shown no mortality benefit
with liberal fluid management as compared to
conservative fluid treatment.19
In addition to the aforementioned proteinaceous
secretions, adipose tissue is also responsible for the
secretion of lipoproteins. Lipoproteins, in particular
high-density lipoprotein (HDL), have been linked
with the delipidation of lipopolysaccharides (LPS).
The delipidated version of the LPS, with density
of less than 1.2 g/cm3 has been shown to have
low virulence when compared to the native LPS
molecule. The low-density LPS was shown to have
decreased activation of the complement pathway
and pyrogenicity in animal models.20,21 Kim and
Nishida have also demonstrated that apoliporotein
A1 has binding sites for plasma disaggregated LPS,
and hence disintegrated LPS can bind to these sites
further inhibiting the systemic effects.22 Interestingly,
obesity has been linked with increased TNF-alpha
production, which is cytokine associated with
hypotension and endothelial damage. On the other
hand, obesity is also associated with increased
lipoproteins, which act as soluble TNF receptors with
the potential to blunt the effect of increased TNF
production in sepsis.23,24
Pepper et al state that the methodology of studies
may have contributed to an apparent but not
real reduction in mortality in septic patients with
overweight and obese BMIs.14 For example, mortality
may not have been adjusted for factors that predict
a favorable outcome in this population. Additionally,
selection bias may have altered results, as obese
patients may have undergone earlier intubation and
mechanical ventilation due to hypoventilation.25,26
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The inability to administer care on the general
medical wards prompted early ICU admission for
obese patients with less severe diseases.3 Moreover,
inaccurate height and weight measurement in the
ICU may have led to assignment of patients into
the wrong BMI category.27-29 The measurement of
weight after fluid resuscitation may have also led
to inaccurate stratification of patients in different
BMI categories.30 Finally, BMI does not differentiate
between muscle and adiposity. Decreased BMI
may be associated with sarcopenia and secondary
protein-calorie malnutrition with decreased albumin
and low oncotic pressure, all of which increase
mortality in sepsis.31
We conducted a post hoc power analysis for our
main outcome variable that was analyzed using chisquare. We used an alpha error probability of 0.05
and a medium effect size of 0.3 with a total sample
size of 252 (excluding individuals with missing
values) which produced a power of 98.7%. This
shows our study was sufficiently powered to detect a
significant difference in our main outcome variable.
There are, however, a few limitations to keep in
mind about our study. The inclusion of patients
from a single center reduces generalizability. This
is a retrospective study that does not demonstrate
causality but only suggests associations. The
results from our analysis did align with the trend
of other studies, however, this was not statistically
significant. Other studies that we have cited had
more statistically significant results. The weight,
height and BMI were obtained from documentation
in the electronic medical records, the accuracy of
which cannot be confirmed. Also, our study has not
accounted for the possibility of measurement bias
that may come from measuring weight and height
across different BMI groups. Our study adds more
evidence to the contingent of studies examining the
obesity paradox.
CONCLUSION
Even though abnormal BMI has a strong association
with increased overall morbidity, our retrospective
study has shown that in our sample it resulted in
equal or lower mortality as compared to normal
control subjects. This seemingly paradoxical result,
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as suggested above, is due to the underlying
immunophysiology and endocrine function of the
adipose tissue. Additionally, the discrepancies in the
methodologies of previous studies may have also
led to an apparent reduction in mortality. One issue
of particular interest is whether lipoproteins, which
confer a protective effect against cytokines and LPS,
can be of use as therapeutic pharmacologic agents in
sepsis. Further studies in the future will be required
to elaborate more on this association.
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